79
17
Growth Score 79 in past quarter
-8 pts
Heat Score 17 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
935745
Abe is a specialized biotech investor and incubator dedicated to developing treatments for Epidermolysis Bullosa.
- Alex Hersham: Founder
About the Company
Abe is a specialised biotech investor and incubator dedicated to developing treatments for Epidermolysis Bullosa (EB), particularly Dystrophic EB (DEB), a severe genetic skin disorder caused by a mutation in the COL7A1 gene. EB causes extremely fragile skin that blisters or tears with minimal friction, and it affects not only the skin but also
internal organs such as the eyes, mouth, and oesophagus.